Source link : https://news.google.com/rss/articles/CBMi0gFBVV95cUxPenNvM2lnazhZOHJCQmtDMmcyZXl4RUprNW9KN1VqZXlLa0pVM0lLeFk4WVdCdk1Ga05wWWlKcWxuX2FVd1d1NzF5dzI5c0RGYlBaYXp4LWYyWVBMWm01OHZZQUJHS205aC1xSk9uOFhMZ29acWFwUXh1QUxSeEVGdUttSDgzMEw5NnlBc2d0VngyRXVHZTN4TFM0U2lET0xwdDZSYmhRTDY0TmRjTDdmSVc3YzVUbkkweTl1T2FWNkxENWJaanMzYVlJbmo0U1JNOGc?oc=5
Author :
Publish date : 2025-02-12 15:58:00
Copyright for syndicated content belongs to the linked Source.
In Slovenia, Novartis opens its first specialized viral vector production facility in Europe – Novartis
ADVERTISEMENT
ADVERTISEMENT
